Analysis of Therapeutic Management Strategies for Anal Suppurations of Crohn's Disease
Launched by RENNES UNIVERSITY HOSPITAL · Dec 9, 2019
Trial Information
Current as of June 28, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the best treatment options for people with anal suppurations related to Crohn's disease. An anal suppuration is an infection in the area around the anus that can happen in some patients with Crohn's disease, and the trial aims to find the most effective combination of treatments that can help patients achieve complete healing both in terms of symptoms and physical condition after 12 months.
To be eligible for this trial, participants must be over 18 years old and scheduled for a drainage procedure due to their anal suppuration from Crohn's disease. They should also be able to understand the study details and agree to participate. However, people who cannot undergo anesthesia or surgery, have other urgent health issues, or have specific personal circumstances that could interfere with the study will not be included. Participants can expect to receive thorough information about the study and its procedures, and their health will be closely monitored throughout the trial to assess the effectiveness of the treatments.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Persons over 18 years of age
- • People suffering from anal suppuration of Crohn's disease for whom a drainage procedure is planned.
- • Person who has received written and oral information about the protocol and has not expressed opposition to participate in the study.
- Exclusion Criteria:
- • No one who is unable to have an anesthetic, structural or psychological examination by MRI and/or surgery.
- • Person planning a planned absence that could hinder participation in the research (travel abroad, relocation, impending transfer);
- • Person with an associated pathology that is a priority for care;
- • Vulnerable person (minors, persons under guardianship or curatorship, or deprived of their liberty by a judicial or administrative decision
About Rennes University Hospital
Rennes University Hospital, a leading academic medical center in France, is dedicated to advancing healthcare through innovative clinical research and trials. With a strong emphasis on patient-centered care, the hospital integrates cutting-edge scientific research with clinical practice, fostering collaboration among multidisciplinary teams. Its commitment to excellence is reflected in its robust infrastructure and expertise in various medical fields, enabling the development and evaluation of novel therapies and treatment protocols. By participating in clinical trials, Rennes University Hospital aims to enhance patient outcomes and contribute to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Rennes, , France
Patients applied
Trial Officials
Laurent SIPROUDHIS, PH-PD
Principal Investigator
Rennes University Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials